Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. scores highest on Nitro (81) and lowest on Price (11). Its PosiPenta is 51.93 out of 100, around the middle of similar companies.
On the Penta Grid this week, Protagonist Therapeutics, Inc. is Grid #253 of 836 in the Healthcare sector in United States, and Grid #1,657 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 51.93 | 11 | 45 | 81 | 79 | 44 |
| Hinge Health, Inc. | 62.78 | 22 | 56 | 94 | 82 | 60 |
| Caris Life Sciences, Inc. | 62.42 | 39 | 47 | 93 | 57 | 77 |
| Kymera Therapeutics, Inc. | 43.41 | 12 | 17 | 82 | 61 | 45 |
| Bruker Corporation | 60.55 | 19 | 76 | 82 | 48 | 78 |
| Twist Bioscience Corporation | 42.60 | 3 | 51 | 68 | 50 | 41 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 125.00 |
| P/B ratio | 9.90 |
EEarnings
| Trailing EPS | ₹97.56 |
| Forward EPS | ₹-14.50 |
NNitro
| Price | 12194.55 |
| 52-week high | 15231.11 |
| 52-week low | 6921.77 |
| Fall from 52-week high | 19.9% |
TTorque
| Return on equity (ROE) | 10.98% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 1.52 |
| Market cap | ₹78,908 Cr |
| Insider holding | 0.71% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Protagonist Therapeutics, Inc.'s PosiPenta score?
Protagonist Therapeutics, Inc.'s PosiPenta is 51.93 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Protagonist Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Protagonist Therapeutics, Inc. is Grid #253 of 836 in the Healthcare sector in United States, and Grid #1,657 of 3,999 in United States.
Which PosiPenta pillar is strongest for Protagonist Therapeutics, Inc.?
Nitro (momentum), with a score of 81 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Protagonist Therapeutics, Inc.?
Price (valuation), with a score of 11 out of 100: much weaker than most similar companies.
Has Protagonist Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 12.58 points, from 39.35 to 51.93.
PositoAI is for research and education only and is not investment advice.